 Mark Sawyer
Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Calculi | 4 | 2024 | 44 | 1.960 |
Why?
| | Appendicitis | 3 | 2024 | 150 | 1.580 |
Why?
| | Nephrolithotomy, Percutaneous | 1 | 2024 | 5 | 0.820 |
Why?
| | Nephrostomy, Percutaneous | 1 | 2024 | 11 | 0.820 |
Why?
| | Urography | 1 | 2023 | 19 | 0.770 |
Why?
| | Radiation Exposure | 1 | 2024 | 63 | 0.770 |
Why?
| | Prostate | 1 | 2024 | 158 | 0.750 |
Why?
| | Surgery, Computer-Assisted | 1 | 2023 | 84 | 0.710 |
Why?
| | Anaphylaxis | 1 | 2023 | 102 | 0.700 |
Why?
| | Drug Hypersensitivity | 1 | 2023 | 89 | 0.700 |
Why?
| | Quality Improvement | 3 | 2024 | 1287 | 0.670 |
Why?
| | Carbon Dioxide | 1 | 2023 | 239 | 0.670 |
Why?
| | Surgical Wound Infection | 1 | 2024 | 330 | 0.640 |
Why?
| | Anti-Infective Agents | 1 | 2023 | 242 | 0.630 |
Why?
| | Contrast Media | 1 | 2023 | 492 | 0.610 |
Why?
| | Anti-Bacterial Agents | 4 | 2024 | 1928 | 0.610 |
Why?
| | Endoscopy | 4 | 2023 | 317 | 0.550 |
Why?
| | Nephrolithiasis | 2 | 2013 | 9 | 0.490 |
Why?
| | Prostatic Neoplasms | 1 | 2024 | 978 | 0.480 |
Why?
| | Urine | 2 | 2013 | 64 | 0.470 |
Why?
| | Urologic Surgical Procedures | 3 | 2010 | 113 | 0.430 |
Why?
| | Whooping Cough | 1 | 2014 | 55 | 0.410 |
Why?
| | Appendectomy | 2 | 2024 | 90 | 0.400 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2014 | 91 | 0.400 |
Why?
| | Calcium | 3 | 2013 | 1182 | 0.370 |
Why?
| | Immunization Programs | 1 | 2014 | 193 | 0.360 |
Why?
| | Antibiotic Prophylaxis | 2 | 2023 | 134 | 0.330 |
Why?
| | Creatinine | 1 | 2012 | 509 | 0.320 |
Why?
| | Cystoscopy | 1 | 2009 | 21 | 0.300 |
Why?
| | Urologists | 2 | 2019 | 17 | 0.300 |
Why?
| | Cystectomy | 1 | 2009 | 42 | 0.300 |
Why?
| | Family | 1 | 2014 | 685 | 0.290 |
Why?
| | Body Weight | 1 | 2013 | 968 | 0.290 |
Why?
| | Urinary Catheterization | 1 | 2008 | 33 | 0.270 |
Why?
| | Catheterization | 1 | 2008 | 183 | 0.250 |
Why?
| | Foreign Bodies | 1 | 2008 | 110 | 0.250 |
Why?
| | Humans | 29 | 2026 | 144667 | 0.240 |
Why?
| | Cholecystitis, Acute | 1 | 2026 | 26 | 0.230 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 2026 | 55 | 0.230 |
Why?
| | Urinary Bladder | 1 | 2008 | 192 | 0.230 |
Why?
| | Cholecystectomy | 1 | 2026 | 61 | 0.230 |
Why?
| | Models, Biological | 1 | 2013 | 1811 | 0.230 |
Why?
| | Metronidazole | 1 | 2024 | 20 | 0.220 |
Why?
| | Ceftriaxone | 1 | 2024 | 21 | 0.220 |
Why?
| | Urologic Diseases | 2 | 2017 | 40 | 0.210 |
Why?
| | Nephrectomy | 2 | 2019 | 158 | 0.200 |
Why?
| | Prone Position | 1 | 2024 | 24 | 0.200 |
Why?
| | Image-Guided Biopsy | 1 | 2024 | 41 | 0.200 |
Why?
| | Supine Position | 1 | 2024 | 37 | 0.200 |
Why?
| | Prostatectomy | 1 | 2024 | 94 | 0.200 |
Why?
| | Quality Indicators, Health Care | 1 | 2026 | 335 | 0.200 |
Why?
| | Clindamycin | 1 | 2023 | 14 | 0.190 |
Why?
| | Surgical Procedures, Operative | 1 | 2026 | 272 | 0.190 |
Why?
| | Intestinal Perforation | 2 | 2005 | 46 | 0.190 |
Why?
| | Patient Positioning | 1 | 2024 | 69 | 0.190 |
Why?
| | Robotic Surgical Procedures | 1 | 2026 | 183 | 0.190 |
Why?
| | Cefazolin | 1 | 2023 | 22 | 0.190 |
Why?
| | Penicillins | 1 | 2023 | 61 | 0.190 |
Why?
| | Rectum | 1 | 2024 | 183 | 0.180 |
Why?
| | Vancomycin | 1 | 2023 | 94 | 0.180 |
Why?
| | Fluoroscopy | 1 | 2023 | 176 | 0.180 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2024 | 260 | 0.170 |
Why?
| | Fractures, Open | 1 | 2021 | 28 | 0.170 |
Why?
| | Acute Disease | 1 | 2024 | 1029 | 0.160 |
Why?
| | Pharmacists | 1 | 2023 | 240 | 0.160 |
Why?
| | Biopsy | 1 | 2024 | 1079 | 0.160 |
Why?
| | Laparoscopy | 3 | 2010 | 477 | 0.160 |
Why?
| | Treatment Outcome | 3 | 2026 | 11735 | 0.160 |
Why?
| | Fuzzy Logic | 1 | 2000 | 13 | 0.160 |
Why?
| | Middle Aged | 11 | 2026 | 35971 | 0.160 |
Why?
| | Refugees | 1 | 2021 | 83 | 0.160 |
Why?
| | Virtual Reality | 1 | 2021 | 82 | 0.150 |
Why?
| | Male | 13 | 2026 | 72431 | 0.150 |
Why?
| | Imaging, Three-Dimensional | 1 | 2023 | 581 | 0.140 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 1999 | 21 | 0.140 |
Why?
| | Young Adult | 4 | 2024 | 14122 | 0.130 |
Why?
| | Low Back Pain | 1 | 2019 | 106 | 0.130 |
Why?
| | Occupational Diseases | 1 | 2019 | 165 | 0.130 |
Why?
| | Men's Health | 1 | 2017 | 6 | 0.130 |
Why?
| | Review Literature as Topic | 1 | 2017 | 52 | 0.120 |
Why?
| | Telemedicine | 1 | 2026 | 957 | 0.120 |
Why?
| | Adult | 8 | 2024 | 40489 | 0.120 |
Why?
| | Aged | 6 | 2026 | 25955 | 0.120 |
Why?
| | Vaccines | 1 | 2021 | 388 | 0.120 |
Why?
| | Ischemia | 1 | 1999 | 422 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 2 | 2023 | 2754 | 0.110 |
Why?
| | Surgeons | 1 | 2019 | 341 | 0.110 |
Why?
| | Female | 10 | 2026 | 78304 | 0.100 |
Why?
| | Liver | 2 | 2000 | 1889 | 0.100 |
Why?
| | Calcium Oxalate | 1 | 2012 | 7 | 0.090 |
Why?
| | Calcium Phosphates | 1 | 2012 | 28 | 0.090 |
Why?
| | Veterans | 1 | 2024 | 1614 | 0.090 |
Why?
| | Secondary Prevention | 1 | 2013 | 255 | 0.090 |
Why?
| | Kidney Pelvis | 1 | 2011 | 22 | 0.090 |
Why?
| | Organ Size | 1 | 2012 | 461 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 1 | 2024 | 3888 | 0.080 |
Why?
| | Endoscopes | 1 | 2010 | 17 | 0.080 |
Why?
| | Biomedical Research | 1 | 2017 | 712 | 0.080 |
Why?
| | Terminology as Topic | 2 | 2010 | 255 | 0.080 |
Why?
| | Urology | 1 | 2010 | 63 | 0.080 |
Why?
| | Ergonomics | 2 | 2019 | 29 | 0.070 |
Why?
| | Socioeconomic Factors | 1 | 2014 | 1322 | 0.070 |
Why?
| | Seasons | 1 | 2012 | 556 | 0.070 |
Why?
| | Urethra | 1 | 2009 | 56 | 0.070 |
Why?
| | Stomach | 1 | 2009 | 109 | 0.070 |
Why?
| | Precision Medicine | 1 | 2013 | 454 | 0.070 |
Why?
| | Ureter | 1 | 2008 | 36 | 0.070 |
Why?
| | Swine | 1 | 2009 | 828 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2014 | 3603 | 0.060 |
Why?
| | Operative Time | 1 | 2026 | 181 | 0.060 |
Why?
| | Ileal Neoplasms | 1 | 2005 | 2 | 0.060 |
Why?
| | Ileal Diseases | 1 | 2005 | 14 | 0.060 |
Why?
| | Drainage | 1 | 2026 | 184 | 0.050 |
Why?
| | Adolescent | 3 | 2014 | 22409 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2014 | 6399 | 0.050 |
Why?
| | Cohort Studies | 1 | 2012 | 5957 | 0.040 |
Why?
| | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2001 | 1 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2026 | 707 | 0.040 |
Why?
| | Mutagens | 1 | 2001 | 27 | 0.040 |
Why?
| | Genes, p53 | 1 | 2001 | 67 | 0.040 |
Why?
| | Hemochromatosis | 1 | 2000 | 9 | 0.040 |
Why?
| | Hepatolenticular Degeneration | 1 | 2000 | 15 | 0.040 |
Why?
| | Prospective Studies | 1 | 2013 | 7994 | 0.040 |
Why?
| | Retrospective Studies | 4 | 2026 | 17149 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2001 | 374 | 0.040 |
Why?
| | Community-Based Participatory Research | 1 | 2021 | 166 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2000 | 315 | 0.040 |
Why?
| | Air | 1 | 1999 | 45 | 0.040 |
Why?
| | Laparotomy | 1 | 1999 | 112 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2019 | 524 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 2005 | 923 | 0.030 |
Why?
| | Global Burden of Disease | 1 | 2017 | 24 | 0.030 |
Why?
| | Urologic Neoplasms | 1 | 2017 | 31 | 0.030 |
Why?
| | Quality-Adjusted Life Years | 1 | 2017 | 122 | 0.030 |
Why?
| | Infertility, Male | 1 | 2017 | 74 | 0.030 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2000 | 532 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2024 | 1569 | 0.030 |
Why?
| | Public Health | 1 | 2021 | 569 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 427 | 0.030 |
Why?
| | Global Health | 1 | 2019 | 401 | 0.030 |
Why?
| | Child | 2 | 2014 | 22600 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2000 | 1159 | 0.030 |
Why?
| | Lung Neoplasms | 2 | 2005 | 2660 | 0.030 |
Why?
| | United States | 2 | 2026 | 16018 | 0.020 |
Why?
| | Mutation | 2 | 2001 | 4081 | 0.020 |
Why?
| | Humidity | 1 | 2012 | 52 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2839 | 0.020 |
Why?
| | Urinalysis | 1 | 2012 | 82 | 0.020 |
Why?
| | Cognition | 1 | 2000 | 1263 | 0.020 |
Why?
| | Animals | 3 | 2009 | 37948 | 0.020 |
Why?
| | Abbreviations as Topic | 1 | 2008 | 2 | 0.020 |
Why?
| | Temperature | 1 | 2012 | 680 | 0.020 |
Why?
| | MEDLINE | 1 | 2008 | 20 | 0.020 |
Why?
| | Databases, Bibliographic | 1 | 2008 | 30 | 0.020 |
Why?
| | Lung | 1 | 2001 | 4089 | 0.020 |
Why?
| | Sarcoma, Experimental | 1 | 1987 | 6 | 0.020 |
Why?
| | Immunization, Passive | 1 | 1987 | 88 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2011 | 8284 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 6041 | 0.020 |
Why?
| | Macrophage Activation | 1 | 1987 | 186 | 0.010 |
Why?
| | Time Factors | 1 | 2017 | 7140 | 0.010 |
Why?
| | Incidence | 1 | 2012 | 2892 | 0.010 |
Why?
| | Mesentery | 1 | 2005 | 44 | 0.010 |
Why?
| | Fatal Outcome | 1 | 2005 | 305 | 0.010 |
Why?
| | Peritoneal Neoplasms | 1 | 2005 | 104 | 0.010 |
Why?
| | Killer Cells, Natural | 1 | 1987 | 470 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 334 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2012 | 5414 | 0.010 |
Why?
| | Codon | 1 | 2001 | 93 | 0.010 |
Why?
| | Hemochromatosis Protein | 1 | 2000 | 3 | 0.010 |
Why?
| | Carcinogens | 1 | 2001 | 123 | 0.010 |
Why?
| | Genes, MHC Class I | 1 | 2000 | 37 | 0.010 |
Why?
| | Free Radicals | 1 | 2000 | 110 | 0.010 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2000 | 161 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2000 | 234 | 0.010 |
Why?
| | Copper | 1 | 2000 | 113 | 0.010 |
Why?
| | Aldehydes | 1 | 2000 | 141 | 0.010 |
Why?
| | Mutagenesis | 1 | 2000 | 194 | 0.010 |
Why?
| | Rabbits | 1 | 2000 | 651 | 0.010 |
Why?
| | HLA Antigens | 1 | 2000 | 235 | 0.010 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2000 | 202 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2001 | 4110 | 0.010 |
Why?
| | Iron | 1 | 2000 | 358 | 0.010 |
Why?
| | Risk Factors | 1 | 2012 | 10796 | 0.010 |
Why?
| | Cell Line | 1 | 2000 | 2821 | 0.010 |
Why?
| | Smoking | 1 | 2001 | 1467 | 0.010 |
Why?
| | Indium | 1 | 1987 | 8 | 0.000 |
Why?
| | Radioisotopes | 1 | 1987 | 37 | 0.000 |
Why?
| | Infant | 1 | 2001 | 10023 | 0.000 |
Why?
| | Child, Preschool | 1 | 2001 | 11790 | 0.000 |
Why?
| | Interleukin-2 | 1 | 1987 | 438 | 0.000 |
Why?
| | Lipopolysaccharides | 1 | 1987 | 854 | 0.000 |
Why?
| | Cell Movement | 1 | 1987 | 959 | 0.000 |
Why?
| | Mice, Inbred C57BL | 1 | 1987 | 5967 | 0.000 |
Why?
| | Mice | 1 | 1987 | 18261 | 0.000 |
Why?
|
|
Sawyer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|